Two- to 9-Year Outcome After Autologous Chondrocyte Transplantation of the Knee
By L. Peterson, T. Minas, M. Brittberg, A. Nilsson, E. Sjögren‐Jansson, A. Lindahl. Clinical Orthopaedics and Related Research, 2000
1,448 citations recorded by the source corpus.
Subfields: Rheumatology, Surgery
View Paper: https://www.semanticscholar.org/paper/b4f73a6e1f2d9c3e6748191e17e74d3b8d0c3b60
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Evy Lundgren Akerlund
- I. Kiviranta
Citations in the corpus
- Repair and tissue engineering techniques for articular cartilage (2014, neutral): “24 27 However, these materials increase the likelihood of an immune reaction to the allogeneic scaffold, and their use is currently considered off-label in the USA.”
- Autologous Chondrocyte Transplantation (2002, methodology): “In addition, the Brittberg visual analog score and a questionnaire with regard to the patient’s perception of the surgical outcome were also used.(28) Treatment durability was defined as the percentage of patients whose outcome was graded good or excellent 2 years after treatment and who maintained ”